Director of ResearchVarmX, Leiden, The NetherlandsLeiden, Zuid-Holland, Netherlands
OC 31.3 - Phase 1 study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of VMX-C001 in healthy subjects
Monday, June 26, 202311:15 – 11:30 ET
PB1145 - Coagulation assays for assessing direct Factor Xa inhibitor oral anticoagulant reversal effects
Tuesday, June 27, 202318:30 – 19:30 ET